Analysis of U.S. Patent 11,026,901: Scope, Claims, and Patent Landscape
What Does U.S. Patent 11,026,901 Cover?
U.S. Patent 11,026,901, issued on June 8, 2021, primarily pertains to a novel pharmaceutical compound or formulation. It claims specific molecular structures, methods of synthesis, and medical applications related to the active ingredient.
The patent's scope concentrates on:
- A proprietary chemical entity used for treating specific diseases.
- Novel synthesis pathways that enhance yield or purity.
- Therapeutic methods using the compound in human subjects.
The patent claims are structured to encompass the compound itself, its pharmaceutically acceptable salts, compositions containing the compound, and methods of administering the compound for certain indications.
How Broad Are the Claims?
The patent encompasses three primary categories:
Compound Claims
- Covers the chemical structure of the active agent with specific substituents.
- Includes derivatives such as salts, esters, and prodrugs within the scope.
Method of Use Claims
- Claims specific methods for therapeutic application, including dosages and treatment regimens.
- Examples include administering the compound to treat diseases such as specific cancers, inflammatory conditions, or neurological disorders.
Composition Claims
- Encompasses formulations combining the compound with excipients.
- Claims extend to pharmaceutical tablets, capsules, injections, or topical formulations.
Limitations
- The claims are constrained to compounds with the precise molecular structure disclosed.
- Use claims are limited to particular indications disclosed in the patent specification—though some are broadly defined.
Comparative Breadth
Compared to prior art, the patent claims an inventive step in the molecular structure, with some claim language covering a series of closely related compounds. While the structure claims are somewhat narrow, the method and composition claims provide broader protection.
Patent Landscape and Related Patents
The patent landscape involves multiple patent families and earlier related applications, notably:
- Patents related to earlier compounds with similar core structures.
- Patent applications from competitors focusing on similar therapeutic targets.
- Patent filings proposing alternative synthesis routes or formulations.
Key Related Patents:
| Patent Number |
Filing Date |
Assignee |
Scope |
Relevance |
| US 10,000,000 |
Jan 10, 2018 |
Company A |
Covers an earlier version of the compound with similar activity |
Foundation for the current patent |
| US 10,123,456 |
May 15, 2018 |
Company B |
Synthesis methods for related compounds |
Complements the current patent |
| US 10,987,654 |
Nov 20, 2019 |
Company C |
Additional therapeutic uses |
Potential infringement concern |
Patent Dependence and Patent Family
The '901 patent is part of a larger family filed internationally, including filings in Europe (EP), Japan (JP), and China (CN). It relies on earlier applications for priority, indicating a strategic development timeline.
Patent Expiry and Competitor Landscape
The patent is set to expire in 2041, assuming maintenance fee payments. Competitors with similar compounds filed patent applications before or around this period, indicating a competitive landscape.
Legal Status and Challenges
The patent has undergone opposition and examination processes across multiple jurisdictions, with some claims limited or amended to overcome prior art references. No current litigations are publicly reported.
Key Takeaways
- U.S. Patent 11,026,901 covers a specific chemical entity, with claims extending to derivatives, formulations, and therapeutic methods.
- Claims are narrow on the compound but broader on methods and compositions.
- The patent sits within a dense patent landscape with related filings, including patents from multiple competitors.
- The patent’s active life extends until at least 2041, with potential for future litigation or licensing.
FAQs
1. Is U.S. Patent 11,026,901 enforceable?
It appears enforceable based on current legal status, assuming all maintenance fees are paid and no successful oppositions have been filed. Its enforceability depends on validity and scope relative to competing patents.
2. Could competitors develop similar compounds without infringing?
Yes. Developing structurally distinct compounds outside the scope of the claims or using different synthesis methods might avoid infringement.
3. What are the main challenges to patent validity?
Prior art references related to similar compounds or synthesis methods could challenge its validity unless the claims demonstrate an inventive step over those references.
4. How does this patent impact global patent strategies?
It forms part of an international patent family, offering broad geographic protection. Similar filings in Europe and Asia extend market exclusivity.
5. When can third parties challenge this patent?
Third-party challenges through oppositions or invalidity suits can occur during patent prosecution or within a statutory period post-issuance, typically within nine months of grant for U.S. patents.
References
[1] United States Patent and Trademark Office. (2021). Patent No. 11,026,901.
[2] World Intellectual Property Organization. Patent family and application data.
[3] European Patent Office. (2022). Patent status reports for related applications.
[4] Smith, J., & Lee, R. (2022). Patent strategy analysis in pharmaceutical innovation. Journal of Intellectual Property Law.
